Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease

Stephen D. Ginsberg, Elliott J. Mufson, Scott E. Counts, Joanne Wuu, Melissa J. Alldred, Ralph A. Nixon, Shaoli Che

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Endocytic alterations are one of the earliest changes to occur in Alzheimer's disease (AD), and are hypothesized to be involved in the selective vulnerability of specific neuronal populations during the progression of AD. Previous microarray and real-time quantitative PCR experiments revealed an upregulation of the early endosomal effector rab5 and the late endosome constituent rab7 in the hippocampus of people with mild cognitive impairment (MCI) and AD. To assess whether these select rab GTPase gene expression changes are reflected in protein levels within selectively vulnerable brain regions (basal forebrain, frontal cortex, and hippocampus) and relatively spared areas (cerebellum and striatum), we performed immunoblot analysis using antibodies directed against rab5 and rab7 on postmortem human brain tissue harvested from cases with a premortem clinical diagnosis of no cognitive impairment (NCI), MCI, and AD. Results indicate selective upregulation of both rab5 and rab7 levels within basal forebrain, frontal cortex, and hippocampus in MCI and AD, which also correlated with Braak staging. In contrast, no differences in protein levels were found in the less vulnerable cerebellum and striatum. These regional immunoblot assays are consistent with single cell gene expression data, and provide protein-based evidence for endosomal markers contributing to the vulnerability of cell types within selective brain regions during the progression of AD.

Original languageEnglish
Pages (from-to)631-639
Number of pages9
JournalJournal of Alzheimer's Disease
Volume22
Issue number2
DOIs
StatePublished - Dec 1 2010
Externally publishedYes

Fingerprint

rab5 GTP-Binding Proteins
Alzheimer Disease
Up-Regulation
Hippocampus
Frontal Lobe
Cerebellum
Brain
rab GTP-Binding Proteins
Gene Expression
Proteins
Endosomes
Cognitive Dysfunction
rab7 protein
Real-Time Polymerase Chain Reaction
Antibodies

Keywords

  • Basal forebrain
  • cerebellum
  • endosome
  • frontal cortex
  • hippocampus
  • mild cognitive impairment
  • rab GTPase
  • selective vulnerability
  • striatum

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease. / Ginsberg, Stephen D.; Mufson, Elliott J.; Counts, Scott E.; Wuu, Joanne; Alldred, Melissa J.; Nixon, Ralph A.; Che, Shaoli.

In: Journal of Alzheimer's Disease, Vol. 22, No. 2, 01.12.2010, p. 631-639.

Research output: Contribution to journalArticle

Ginsberg, Stephen D. ; Mufson, Elliott J. ; Counts, Scott E. ; Wuu, Joanne ; Alldred, Melissa J. ; Nixon, Ralph A. ; Che, Shaoli. / Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease. In: Journal of Alzheimer's Disease. 2010 ; Vol. 22, No. 2. pp. 631-639.
@article{5d3c4e9832a04ab88107162d23918c89,
title = "Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease",
abstract = "Endocytic alterations are one of the earliest changes to occur in Alzheimer's disease (AD), and are hypothesized to be involved in the selective vulnerability of specific neuronal populations during the progression of AD. Previous microarray and real-time quantitative PCR experiments revealed an upregulation of the early endosomal effector rab5 and the late endosome constituent rab7 in the hippocampus of people with mild cognitive impairment (MCI) and AD. To assess whether these select rab GTPase gene expression changes are reflected in protein levels within selectively vulnerable brain regions (basal forebrain, frontal cortex, and hippocampus) and relatively spared areas (cerebellum and striatum), we performed immunoblot analysis using antibodies directed against rab5 and rab7 on postmortem human brain tissue harvested from cases with a premortem clinical diagnosis of no cognitive impairment (NCI), MCI, and AD. Results indicate selective upregulation of both rab5 and rab7 levels within basal forebrain, frontal cortex, and hippocampus in MCI and AD, which also correlated with Braak staging. In contrast, no differences in protein levels were found in the less vulnerable cerebellum and striatum. These regional immunoblot assays are consistent with single cell gene expression data, and provide protein-based evidence for endosomal markers contributing to the vulnerability of cell types within selective brain regions during the progression of AD.",
keywords = "Basal forebrain, cerebellum, endosome, frontal cortex, hippocampus, mild cognitive impairment, rab GTPase, selective vulnerability, striatum",
author = "Ginsberg, {Stephen D.} and Mufson, {Elliott J.} and Counts, {Scott E.} and Joanne Wuu and Alldred, {Melissa J.} and Nixon, {Ralph A.} and Shaoli Che",
year = "2010",
month = "12",
day = "1",
doi = "10.3233/JAD-2010-101080",
language = "English",
volume = "22",
pages = "631--639",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease

AU - Ginsberg, Stephen D.

AU - Mufson, Elliott J.

AU - Counts, Scott E.

AU - Wuu, Joanne

AU - Alldred, Melissa J.

AU - Nixon, Ralph A.

AU - Che, Shaoli

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Endocytic alterations are one of the earliest changes to occur in Alzheimer's disease (AD), and are hypothesized to be involved in the selective vulnerability of specific neuronal populations during the progression of AD. Previous microarray and real-time quantitative PCR experiments revealed an upregulation of the early endosomal effector rab5 and the late endosome constituent rab7 in the hippocampus of people with mild cognitive impairment (MCI) and AD. To assess whether these select rab GTPase gene expression changes are reflected in protein levels within selectively vulnerable brain regions (basal forebrain, frontal cortex, and hippocampus) and relatively spared areas (cerebellum and striatum), we performed immunoblot analysis using antibodies directed against rab5 and rab7 on postmortem human brain tissue harvested from cases with a premortem clinical diagnosis of no cognitive impairment (NCI), MCI, and AD. Results indicate selective upregulation of both rab5 and rab7 levels within basal forebrain, frontal cortex, and hippocampus in MCI and AD, which also correlated with Braak staging. In contrast, no differences in protein levels were found in the less vulnerable cerebellum and striatum. These regional immunoblot assays are consistent with single cell gene expression data, and provide protein-based evidence for endosomal markers contributing to the vulnerability of cell types within selective brain regions during the progression of AD.

AB - Endocytic alterations are one of the earliest changes to occur in Alzheimer's disease (AD), and are hypothesized to be involved in the selective vulnerability of specific neuronal populations during the progression of AD. Previous microarray and real-time quantitative PCR experiments revealed an upregulation of the early endosomal effector rab5 and the late endosome constituent rab7 in the hippocampus of people with mild cognitive impairment (MCI) and AD. To assess whether these select rab GTPase gene expression changes are reflected in protein levels within selectively vulnerable brain regions (basal forebrain, frontal cortex, and hippocampus) and relatively spared areas (cerebellum and striatum), we performed immunoblot analysis using antibodies directed against rab5 and rab7 on postmortem human brain tissue harvested from cases with a premortem clinical diagnosis of no cognitive impairment (NCI), MCI, and AD. Results indicate selective upregulation of both rab5 and rab7 levels within basal forebrain, frontal cortex, and hippocampus in MCI and AD, which also correlated with Braak staging. In contrast, no differences in protein levels were found in the less vulnerable cerebellum and striatum. These regional immunoblot assays are consistent with single cell gene expression data, and provide protein-based evidence for endosomal markers contributing to the vulnerability of cell types within selective brain regions during the progression of AD.

KW - Basal forebrain

KW - cerebellum

KW - endosome

KW - frontal cortex

KW - hippocampus

KW - mild cognitive impairment

KW - rab GTPase

KW - selective vulnerability

KW - striatum

UR - http://www.scopus.com/inward/record.url?scp=78650803250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650803250&partnerID=8YFLogxK

U2 - 10.3233/JAD-2010-101080

DO - 10.3233/JAD-2010-101080

M3 - Article

C2 - 20847427

AN - SCOPUS:78650803250

VL - 22

SP - 631

EP - 639

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -